Related Experiment Video
Updated: Aug 12, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Influence of positive inotropic agents on intracellular calcium transients. Part II. Cardiomyopathic hamster hearts
T Stefenelli1, S T Wu, W W Parmley
1Department of Medicine (Cardiology), University of California, San Francisco 94143.
Insights
Dobutamine worsened heart function and increased calcium in failing hearts, unlike norepinephrine and isoproterenol. This study investigates dobutamine
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Background:
- End-stage heart failure presents complex challenges in myocardial performance.
- Understanding the mechanisms of inotropic agents is crucial for treatment.
Purpose of the Study:
- To investigate the effects of dobutamine on myocardial performance in end-stage heart failure.
- To compare dobutamine's mechanism with norepinephrine and isoproterenol.
Main Methods:
- Hemodynamic responses, high-energy phosphates (31P-NMR), and intracellular calcium ([Ca2+]i) transients were measured.
- Syrian cardiomyopathic hamsters with severe heart failure were perfused with dobutamine, norepinephrine, or isoproterenol (10(-6) mol/L).
Main Results:
- All agents initially increased the rate-pressure product, but dobutamine caused a subsequent decrease.
- Dobutamine increased end-diastolic intracellular calcium ([Ca2+]i) by 19%, while norepinephrine and isoproterenol decreased it.
- No significant differences were observed in coronary flow, pHi, high-energy phosphates, or phosphorylation potential among the agents.
Conclusions:
- Dobutamine depressed myocardial performance in late heart failure, contrasting with norepinephrine and isoproterenol.
- Dobutamine uniquely increased end-diastolic intracellular calcium ([Ca2+]i) in this model.
Abstract:
To study the mechanism of dobutamine on end-stage heart failure, we assessed hemodynamic responses, high-energy phosphates (31P-NMR), and free intracellular calcium ([Ca2+]i) transients (surface fluorometry) during perfusion with 10(-6) mol/L dobutamine in Syrian cardiomyopathic hamsters with severe heart failure. These results were compared to perfusion of the heart with 10(-6) mol/L norepinephrine and 10(-6) mol/L isoproterenol. With the positive inotropic agents the rate-pressure product increased immediately (p less than 0.01 with dobutamine, norepinephrine; p less than 0.003 with isoproterenol); after 10 to 15 minutes of perfusion the rate-pressure product remained relatively stable with norepinephrine and isoproterenol but decreased with dobutamine (p = NS vs control values). [Ca2+]i-transients increased significantly in all groups. The end-diastolic [Ca2+]i decreased continuously with norepinephrine and isoproterenol (p less than 0.008; p less than 0.005) but increased during dobutamine by 19%. Alterations in coronary flow, pHi, high-energy phosphates, and the phosphorylation potential were not significantly different among the three catecholamines. In conclusion, in contrast to norepinephrine and isoproterenol, dobutamine depressed myocardial performance and increased end-diastolic [Ca2+]i in late heart failure.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
Heart Failure Drugs: Inotropic Agents

